Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AstraZeneca

Scientists hail ‘landmark moment’ in the treatment of advanced breast cancer

Capivasertib is being made by pharmaceutical giant AstraZeneca following a programme of drug discovery research at the Institute of Cancer Research.

The Independent UK

‘Landmark moment’ in breast cancer treatment could save thousands of lives each year

‘The treatment is far less debilitating than chemotherapy and I’ve been given the gift of a longer life,’ says one patient

The Independent UK

The business of clinical trials is booming. Private equity has taken notice

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Mum-of-two left in coma after Covid jab now diagnosed with rare and serious condition

Sarah Birch, 46, from Rochester, Kent, fell desperately ill after receiving her Covid vaccine last year and was in a coma for four days

Daily Mirror

Mum seeking compensation after falling into coma days after Covid jab

Sarah has been left unable to work and has been bed-bound for months

Wales Online

Shares surge in drug discovery company after $402m AstraZeneca deal announced

Shares in C4X Discovery Holdings plc have jumped since the deal was announced

Birmingham Post

AstraZeneca’s CEO on Covid: ‘We Just Have to Adjust to it’

AstraZeneca’s Chief Executive Officer, Sir Pascal Soriot, told Asharq Al-Awsat in an interview that Covid-19 is not over “and we just have to adjust to it like we live with the flu.” “Most people who get it basically get sick for a few days and do not need to be…

Asharq Al-Awsat

Read news from The Economist, FT, and more,
with one subscription

Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11

Bloomberg

Benzinga

AstraZeneca drops plans for Covid jab approval in US

The drugs giant will instead focus its Covid-19 vaccine efforts elsewhere globally and for its use as a booster.

The Independent UK

Expert warns of winter Covid surge

A Chulalongkorn University virologist has warned about a potential surge in Covid-19 cases during the cold season that will likely peak in January.

Bangkok Post

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

The Guardian - UK

Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization Next Year: Top Stories Tuesday, Nov. 1

Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production

Benzinga

Intel's Self-Driving Tech Firm Raises Over $800M In IPO, Alphabet Misses Q3 Earnings Expectations, Lyft Cuts Price For Monthly Subscription Plan: Top Stories Wednesday, Oct. 26

Benzinga

High Hopes for Nasal Covid Vaccines despite 'Disappointing' Trial

Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say. By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that lines the nose and…

Asharq Al-Awsat

Get all your
news in one place.

100's of premium titles.
One news app.

ABC News

What vaccine can you get, based on your age? These are the recommended COVID-19 vaccines for each age group

More than 14.2 million Australians over the age of 16 have now received three or more doses. So which are the best vaccines for each age group?

The Independent UK

Super-gene that generates higher antibodies against Covid discovered

People carrying the super-gene recorded higher antibody responses against the Covid-19 vaccines 28 days following the first dose

The Independent UK

Japan reopening: What are the current travel rules and do I need a Covid test?

The country reopened to individual tourists on 11 October

The Independent UK

Hillary Clinton giving girls Instagram access to ‘stand up for gender equality’

The former US presidential hopeful was supporting the United Nations’ International Day Of The Girl.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Covid: hopes for Oxford nasal vaccine dealt blow after poor trial results

Scientists ditch plans to develop nasal spray version of Oxford/AstraZeneca vaccine in its current form

The Guardian - UK

Ex-vaccine head accuses Hancock of ‘Jekyll and Hyde’ behaviour in meeting

Dame Kate Bingham says former health secretary aggressively questioned her competence in front of cabinet

The Independent UK

Trainee solicitor died from ‘rare complication’ of AstraZeneca Covid-19 jab

Oli Akram Hoque, 26, developed a “vaccine induced” cerebral venous sinuous thrombosis after his first dose of AstraZeneca’s Covid-19 vaccine.

The Conversation

Pollen does more than make you sneeze. It can cause thunderstorm asthma, even if you're not asthmatic

Climate change has caused melting icebergs, flooding, and landslides. It can also bring about an increase in pollen levels, prolong the duration of pollen season, and cause more pollen-related health problems.

Benzinga

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Benzinga

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

The Guardian - UK

Revealed: the budget bonanza for UK’s best-paid bosses from Tory tax cut

Scrapping top rate of tax could save hundreds of thousands for some of the highest earners, analysis reveals

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.